Dana Pizzuti, Chief Med and Development Officer at Crinetics Pharmaceuticals, Inc. (CRNX), sold 19,464 shares at $45.89 ($866K) on 2024-03-20, disclosed to the SEC on 2024-03-22.
Open-market sale of $866k CRNX by Chief Med and Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.28 | 10,000 | $433K | 50.0% |
| 2 | $43.69 | 714 | $31K | 3.6% |
| 3 | $45.89 | 4,375 | $201K | 23.2% |
| 4 | $45.89 | 4,375 | $201K | 23.2% |
| Total | $44.47 avg | 19,464 | $866K | 100% |
| Filing → |
| CRNX | SELL | 2025-10-03 | $209K | — | Filing → |
| CRNX | SELL | 2025-09-04 | $161K | — | Filing → |
| CRNX | SELL | 2025-08-26 | $913K | — | Filing → |